Stock of the Day
February 23, 2024
Larimar Therapeutics (LRMR)
$2.73
+$0.27 (+10.8%)
Market Cap:
$174.86M
About Larimar Therapeutics
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease.
Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.
← Previous Stock of the Day
Next Stock of the Day →